Luca Caracciolo

Tumor necrosis factor-α synthesis inhibitor 3,6′-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer’s disease

David Tweedie, Ryan Ferguson, Kelly Fishman et al. · Journal of Neuroinflammation · 2012 · 210 citations · Full text

CREB controls cortical circuit plasticity and functional recovery after stroke

Luca Caracciolo, Máté Marosi, Jose A. Mazzitelli et al. · Nature Communications · 2018 · 148 citations · Full text

Synaptic Transmission, Stroke Rehabilitation, Stroke +20

Cyclooxygenase‐1 inhibition reduces amyloid pathology and improves memory deficits in a mouse model of Alzheimer's disease

Sangho Choi, Saba Aïd, Luca Caracciolo et al. · Journal of Neurochemistry · 2012 · 127 citations · Full text

Neurochemical Biomarkers, Social Sciences, Oxidative Stress +25

Chronic antidepressant treatments induce a time-dependent up-regulation of AMPA receptor subunit protein levels

Alessandro Barbon, Luca Caracciolo, Cesare Orlandi et al. · Neurochemistry International · 2011 · 70 citations

Chronic Antidepressant Treatments, Psychiatry, Mood Symptom +13

3,6′‐Dithiothalidomide, a new TNF‐α synthesis inhibitor, attenuates the effect of Aβ_1–42intracerebroventricular injection on hippocampal neurogenesis and memory deficit

Isabella Russo, Luca Caracciolo, David Tweedie et al. · Journal of Neurochemistry · 2012 · 63 citations · Full text